146 results on '"Keita Sakamoto"'
Search Results
2. Two cases of airway-centered fibroelastosis treated with an antifibrotic agent and corticosteroids
- Author
-
Miwa Kamatani, Minoru Inomata, Akari Misumi, Ken Ito, Takashi Maeda, Haruka Chin, Yu Ito, Keita Sakamoto, Nobuyasu Awano, Naoyuki Kuse, Yoshiaki Furuhata, Yuan Bae, Hiroaki Sugiura, Tamiko Takemura, and Takehiro Izumo
- Subjects
Airway-centered fibroelastosis ,Pleuroparenchymal fibroelastosis ,Nintedanib ,Corticosteroids ,Progressive fibrosing interstitial lung disease ,Diseases of the respiratory system ,RC705-779 - Abstract
Airway-centered fibroelastosis is characterized by peribronchovascular fibroelastosis, predominantly in the upper lobes, with little-to-no pleural involvement. In this study, we describe two cases of airway-centered fibroelastosis diagnosed based on radiological and pathological findings. The first case comprised a 44-year-old man whose forced vital capacity improved over three months following treatment with nintedanib. The second case involved a 50-year-old woman who was treated with oral corticosteroids but yielded an unfavorable outcome. An effective treatment for airway-centered fibroelastosis has not yet been identified; therefore, this study may help contribute to a more thorough discussion regarding treatment strategies for this disease.
- Published
- 2024
- Full Text
- View/download PDF
3. Clinical usefulness of end‐tidal CO2 measured using a portable capnometer in patients with respiratory disease
- Author
-
Manabu Suzuki, Shota Fujimoto, Keita Sakamoto, Kentaro Tamura, Satoru Ishii, Motoyasu Iikura, Shinyu Izumi, Yuichiro Takeda, Masayuki Hojo, and Haruhito Sugiyama
- Subjects
capnometer ,EtCO2 ,PaCO2 ,PvCO2 ,respiratory care ,respiratory medicine ,Diseases of the respiratory system ,RC705-779 - Abstract
Abstract Introduction This study aimed to evaluate the correlation and agreement between end‐tidal CO2 (EtCO2) measured with the novel portable capnometer (CapnoEye®) and partial pressure of arterial carbon dioxide (PaCO2) levels in patients with respiratory diseases and to compare the efficacy of EtCO2 and PvCO2 in predicting PaCO2 levels. Methods We analyzed the correlation and the agreement between EtCO2 and PaCO2 and between PvCO2 and PaCO2 using Pearson's moment correlation coefficient in patients with type 1 and type 2 respiratory failure and both groups overall. Results A total of 100 samples were included that comprised 67 men (67%). The mean age of the subjects was 77 ± 13 years. Chronic obstructive pulmonary disease (COPD) (43%) was the most common disease. There was a high correlation between EtCO2 and PaCO2 (r = 0.88; p < 0.0001). Sixty‐six PvCO2 samples were obtained, and there was a high correlation between PvCO2 and PaCO2 (r = 0.81; p < 0.0001). Regarding type 2 respiratory failure, there was a high correlation between EtCO2 and PaCO2 (r = 0.81). The Bland–Altman analysis between PaCO2 and EtCO2 revealed a bias of 5.7 mmHg, with limits of agreement ranging from −5.1 mmHg to 16.5 mmHg. In contrast, the analysis between PaCO2 and PvCO2 revealed a bias of −6.8 mmHg, and the limits of agreement ranged from −22.13 mmHg to 8.53 mmHg. Conclusion EtCO2 measured by CapnoEye® was significantly correlated to PaCO2 levels in patients with respiratory diseases. Moreover, CapnoEye® may be more useful for predicting hypercapnia conditions in which respiratory diseases are compared with measure PvCO2.
- Published
- 2023
- Full Text
- View/download PDF
4. Adult T-cell leukemia/lymphoma complicated by Pneumocystis pneumonia in a non-endemic area
- Author
-
Mayu Kunimoto, Minoru Inomata, Haruka Chin, Yu Ito, Kazushi Fujimoto, Yutaka Muto, Moe Nomura, Kota Sato, Keita Sakamoto, Nobuyasu Awano, Naoyuki Kuse, Toshio Kumasaka, Tamiko Takemura, and Takehiro Izumo
- Subjects
Adult T-cell leukemia/lymphoma (ATLL) ,Human T-cell leukemia virus type 1 (HTLV-1) ,Pneumocystis pneumonia (PCP) ,Diseases of the respiratory system ,RC705-779 - Abstract
Adult T-cell leukemia/lymphoma (ATLL) is a human T-cell leukemia virus type 1-inducing unevenly-distributed T-cell malignancy, which is often complicated by opportunistic infections. Here, we discuss the case of a 75-year-old woman presenting with Pneumocystis pneumonia (PCP) who was subsequently diagnosed with ATLL in Tokyo, a non-endemic area of ATLL. In addition to the elevated soluble interleukin-2 receptor and the detection of flower cells in the screening blood test, the high-resolution computed tomography findings, atypical of PCP, were clues to the diagnosis of ATLL. ATLL should be considered as an underlying disease when patients present with PCP, even in non-endemic areas.
- Published
- 2023
- Full Text
- View/download PDF
5. Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study
- Author
-
Satoshi Ikeda, Toshihiro Misumi, Shinyu Izumi, Keita Sakamoto, Naoki Nishimura, Shosei Ro, Koichi Fukunaga, Satoshi Okamori, Natsuo Tachikawa, Nobuyuki Miyata, Masaharu Shinkai, Masahiro Shinoda, Yasunari Miyazaki, Yuki Iijima, Takehiro Izumo, Minoru Inomata, Masaki Okamoto, Tomoyoshi Yamaguchi, Keisuke Iwabuchi, Makoto Masuda, Hiroyuki Takoi, Yoshitaka Oyamada, Shigeki Fujitani, Masamichi Mineshita, Haruyuki Ishii, Atsushi Nakagawa, Nobuhiro Yamaguchi, Makoto Hibino, Kenji Tsushima, Tatsuya Nagai, Satoru Ishikawa, Nobuhisa Ishikawa, Yasuhiro Kondoh, Yoshitaka Yamazaki, Kyoko Gocho, Tomotaka Nishizawa, Akifumi Tsuzuku, Kazuma Yagi, Yuichiro Shindo, Yuriko Takeda, Takeharu Yamanaka, and Takashi Ogura
- Subjects
Medicine ,Science - Abstract
Abstract Corticosteroids use in coronavirus disease 2019 (COVID-19) is controversial, especially in mild to severe patients who do not require invasive/noninvasive ventilation. Moreover, many factors remain unclear regarding the appropriate use of corticosteroids for COVID-19. In this context, this multicenter, retrospective, propensity score–matched study was launched to evaluate the efficacy of systemic corticosteroid administration for hospitalized patients with COVID-19 ranging in the degree of severity from mild to critically-ill disease. This multicenter, retrospective study enrolled consecutive hospitalized COVID-19 patients diagnosed January–April 2020 across 30 institutions in Japan. Clinical outcomes were compared for COVID-19 patients who received or did not receive corticosteroids, after adjusting for propensity scores. The primary endpoint was the odds ratio (OR) for improvement on a 7-point ordinal score on Day 15. Of 1092 COVID-19 patients analyzed, 118 patients were assigned to either the corticosteroid and non-corticosteroid group, after propensity score matching. At baseline, most patients did not require invasive/noninvasive ventilation (85.6% corticosteroid group vs. 89.8% non-corticosteroid group). The odds of improvement in a 7-point ordinal score on Day 15 was significantly lower for the corticosteroid versus non-corticosteroid group (OR, 0.611; 95% confidence interval [CI], 0.388–0.962; p = 0.034). The time to improvement in radiological findings was significantly shorter in the corticosteroid versus non-corticosteroid group (hazard ratio [HR], 1.758; 95% CI, 1.323–2.337; p
- Published
- 2021
- Full Text
- View/download PDF
6. Evaluation of whole-body modalities for diagnosis of multifocal osteonecrosis—a pilot study
- Author
-
Shunichi Yokota, Keita Sakamoto, Yukie Shimizu, Tsuyoshi Asano, Daisuke Takahashi, Kohsuke Kudo, Norimasa Iwasaki, and Tomohiro Shimizu
- Subjects
Osteonecrosis ,Whole-body magnetic resonance imaging ,Whole-body bone scintigraphy ,Steroid ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
Abstract Background This study aimed to investigate the ability of whole-body bone scintigraphy (WB-BS) in the detection of multifocal osteonecrosis (ON) compared to whole-body magnetic resonance imaging (WB-MRI) and to clarify the characteristics of patients with multifocal ON among those with ON of the femoral head (ONFH) using WB-MRI. Methods Forty-six patients who had symptomatic ONFH and underwent surgery in our hospital from April 2019 to October 2020 were included in the study. Data on patient demographics, including age, sex, body mass index (BMI), history of corticosteroid intake, alcohol abuse, smoking, and symptomatic joints, were collected from their medical records. All patients underwent WB-MRI and WB-BS before surgery. Results The agreement in the detection of ON by WB-MRI vs the uptake lesions by WB-BS in the hip joints was moderate (κ = 0.584), while that in other joints was low (κ
- Published
- 2021
- Full Text
- View/download PDF
7. Pembrolizumab‐induced pancytopenia in a patient with squamous cell lung cancer
- Author
-
Yuriko Ueki, Manabu Suzuki, Yuriko Horikawa, Hiromu Watanabe, Yoh Yamaguchi, Chie Morita, Akinari Tsukada, Hiroshi Takumida, Yusaku Kusaba, Takashi Katsuno, Yoshie Tsujimoto, Keita Sakamoto, Masao Hashimoto, Junko Terada, Satoru Ishii, Jin Takasaki, Go Naka, Motoyasu Iikura, Shinyu Izumi, Yuichiro Takeda, Masayuki Hojo, and Haruhito Sugiyama
- Subjects
Immune checkpoint inhibitor ,immune‐related adverse event (irAE) ,pancytopenia ,PD‐L1 ,squamous cell lung cancer ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Immune checkpoint inhibitors (ICIs) are reportedly effective against many kinds of neoplasm, but may be responsible for several kinds of immune‐related adverse events (irAEs). Among these irAEs, the incidence of myelosuppression due to ICIs is relatively low. Corticosteroids are needed to control most cases of myelosuppression. Here, we report an 88‐year‐old woman with squamous cell lung cancer who was administered pembrolizumab. After five cycles of pembrolizumab, she developed severe pancytopenia. The pancytopenia improved under observation without steroid administration after cessation of pembrolizumab. During recovery from this irAE, the patient also maintained long‐term antitumor efficacy. Key points Significant findings of the study There are several kinds of immune‐related adverse events. We encountered a case of pembrolizumab‐induced pancytopenia with squamous cell lung cancer. What this study adds Corticosteroids are needed to control most cases of myelosuppression induced by ICIs, but pancytopenia induced by pembrolizumab in our case improved without steroids.
- Published
- 2020
- Full Text
- View/download PDF
8. Pulmonary amyloidosis diagnosed via transbronchial lung cryobiopsy without surgical lung biopsy: A case series
- Author
-
Kazushi Fujimoto, Minoru Inomata, Yu Ito, Haruko Matsumoto, Ayae Saiki, Keita Sakamoto, Nobuyasu Awano, Naoyuki Kuse, Toshio Kumasaka, and Takehiro Izumo
- Subjects
Pulmonary amyloidosis ,Surgical lung biopsy ,Transbronchial cryobiopsy ,Diseases of the respiratory system ,RC705-779 - Abstract
Pulmonary amyloidosis is a rare disease characterized by abnormal extracellular deposition of amyloid fibril in the lung tissue, and the identification of amyloid deposits is essential for its diagnosis. Surgical lung biopsy (SLB) is a standard diagnostic method for pulmonary amyloidosis. However, it has a relatively high post-procedural mortality rate. Recently, transbronchial lung cryobiopsy (TBLC) has been gradually used for diagnosing interstitial lung disease. However, its diagnostic efficacy for pulmonary amyloidosis has not yet been validated. Here, we describe two cases of pulmonary amyloidosis with deposition of amyloid light chain detected via TBLC. Since SLB is a high-risk procedure for the patients due to age and complications, TBLC was performed. Both patients presented with Congo red-positive amyloid deposits. One patient with localized pulmonary amyloidosis had a good clinical course without therapeutic intervention and was followed up. The other with systemic amyloidosis received chemotherapy and presented with a stable clinical course. TBLC can collect a larger pulmonary specimen for pulmonary amyloidosis than forceps biopsy and has fewer complications and a lower mortality rate than SLB. Thus, it can be a diagnostic method for pulmonary amyloidosis.
- Published
- 2022
- Full Text
- View/download PDF
9. Can the Number of Radiofrequency Activations Predict Serious Adverse Events after Bronchial Thermoplasty? A Retrospective Case-Control Study
- Author
-
Shota Yamamoto, Motoyasu Iikura, Tamaki Kakuwa, Yoshie Tsujimoto, Sachi Matsubayashi, Naoko Nagano, Tomoyuki Suzuki, Keita Sakamoto, Konomi Kobayashi, Ayako Shiozawa, Masao Hashimoto, Satoru Ishii, Manabu Suzuki, Shinyu Izumi, Masayuki Hojo, Terumitsu Hasebe, and Haruhito Sugiyama
- Subjects
Bronchial asthma ,Bronchial thermoplasty ,Lung function tests ,Serious adverse events ,Diseases of the respiratory system ,RC705-779 - Abstract
Abstract Introduction Bronchial thermoplasty (BT) is a bronchoscopic procedure that involves the delivery of thermal radiofrequency energy to the bronchial wall for treating severe asthma. It has been suggested that too many radiofrequency activations could induce serious adverse events (SAEs) at an early stage. We aimed to examine the number of radiofrequency activations at each session and early lung function changes from baseline to determine whether these are related to SAEs. Methods We retrospectively investigated 13 consecutive patients who underwent three sessions each of BT for severe asthma from February 2015 to January 2016. Lung function tests were performed on the day before and after each BT procedure. Since we compared the number of activations and lung function changes from baseline after each session, a total of 39 sessions were reviewed. The relationship between the number of radiofrequency activations and each lung function change from baseline was also examined by linear regression analysis. Results A total of 10 SAEs (4 of pneumonia, 3 of atelectasis, 2 of bronchial asthma exacerbation and 1 of hemoptysis) were observed following the 39 BT sessions. When we compared sessions with and without SAEs, there were no differences in the number of activations (mean ± SD, 71.5 ± 28.6 times in sessions with SAEs; 66.5 ± 25.1 times in sessions without SAEs; p = 0.772) and lung function changes (mean changes in FVC/%FVC/FEV1/%FEV1/%PEF from baseline; − 0.49 l/− 14.2%/− 0.36 l/− 11.7%/− 9.6% in sessions with SAEs; − 0.43 l/− 13.3%/− 0.34 l/− 12.1%/− 9.4% in sessions without SAEs; p > 0.05 for all the above). Increase in the number of activations correlated with decreased FEV1 (R 2 = 0.17, p = 0.0088) and %FEV1 (R 2 = 0.11, p = 0.0357). Conclusions Increase in the number of radiofrequency activations during BT is related to a decrease in FEV1 and %FEV1 from baseline. The number of radiofrequency activations, however, is not associated with SAEs after BT.
- Published
- 2019
- Full Text
- View/download PDF
10. Assessment of valgus laxity after release of the medial structure in medial open-wedge high tibial osteotomy: an in vivo biomechanical study using quantitative valgus stress radiography
- Author
-
Dai Sato, Eiji Kondo, Koji Yabuuchi, Jun Onodera, Tomohiro Onodera, Tomonori Yagi, Keita Sakamoto, Akira Takasawa, Norimasa Iwasaki, and Kazunori Yasuda
- Subjects
Medial open-wedge high tibial osteotomy ,Superficial layer of the medial collateral ligament ,Valgus instability ,Valgus stress test ,Diseases of the musculoskeletal system ,RC925-935 - Abstract
Abstract Background To perform medial open-wedge high tibial osteotomy (OWHTO), surgeons expose the medial-proximal tibia by releasing or cutting the superficial layer of the medial collateral ligament (sMCL). Biomechanically, the sMCL provides primary restraint against valgus forces. Therefore, any release of the sMCL can cause valgus instability of the knee joint. The purpose of this study was to assess valgus laxity after release of the medial structure of the knee during OWHTO. Methods Between 2009 and 2015, 84 consecutive patients (93 knees) who underwent OWHTO using a locking plate were enrolled in this study. All patients underwent radiological examinations before surgery, during surgery, 1 year after surgery, and after plate removal to objectively assess valgus laxity. The medial joint space (MJS) and the joint line convergence angle (JLCA) of the knee were evaluated using quantitative valgus stress radiography. Clinical evaluation was performed 2 years after surgery. Results The mean functional knee score improved significantly, from 65.5 to 91.1 points (p
- Published
- 2019
- Full Text
- View/download PDF
11. Three different CT and FDG PET/CT findings of pulmonary involvement in methotrexate‐associated lymphoproliferative disease
- Author
-
Sachi Matsubayashi, Manabu Suzuki, Keita Sakamoto, Shinyu Izumi, Masayuki Hojo, and Haruhito Sugiyama
- Subjects
Diffuse large B‐cell lymphoma ,Epstein–Barr reactivation or Epstein–Barr infection ,methotrexate ,psoriasis ,rheumatoid arthritis ,Diseases of the respiratory system ,RC705-779 - Abstract
Lymphoproliferative disease (LPD) is one of the complications of methotrexate (MTX) therapy. In MTX‐associated LPD (MTX‐LPD), LPD lesions limited to the lungs are rare and show various types of opacity. A 75‐year‐old woman with rheumatoid arthritis (RA) presented with myalgia. She had been taking MTX for 11 years. Chest computed tomography (CT) scans showed a nodule in the left lower lobe that had grown significantly and a new nodule in the right lower lobe. 18F‐fluorodeoxyglucose (FDG)/positron emission tomography (PET)/CT revealed significant FDG uptake in these nodules. Transbronchial biopsy specimen showed diffusely distributed CD20‐positive lymphoid cells, and we made a diagnosis of MTX‐LPD. All lung lesions disappeared within months after the immediate discontinuation of MTX. We also had two other patients with MTX‐LPD lung lesions that had high FDG uptake. FDG PET/CT might be a useful diagnostic tool as it may reflect disease progression and help identify separate lesions.
- Published
- 2020
- Full Text
- View/download PDF
12. A successful treatment of rheumatoid arthritis-related interstitial pneumonia with nintedanib
- Author
-
Tamaki Kakuwa, Shinyu Izumi, Keita Sakamoto, Tomoyuki Suzuki, Motoyasu Iikura, and Haruhito Sugiyama
- Subjects
Diseases of the respiratory system ,RC705-779 - Abstract
Rheumatoid arthritis-related interstitial pneumonia with a usual interstitial pneumonia (RA-UIP) has a poor prognosis and a new treatment strategy is required. The antifibrotic agent nintedanib reduces the annual rate of decline in forced vital capacity (FVC) in idiopathic pulmonary fibrosis (IPF) patients. Recently, the potential efficacy of antifibrotic agents against chronic progressive fibrotic diseases including RA-UIP has been attracting attention.A 74-year-old man diagnosed with IPF on high-resolution computed tomography (HRCT). His FVC was decreasing over time, and his exertional dyspnea and cough had progressed with progression of reticulation on imaging. He was treated with nintedanib, which resulted in decreased coughing together with a reduction in FVC decline, from −11.6%/year to −5.2%/year. A swollen joint appeared eight months after this intervention, and he was diagnosed with rheumatoid arthritis.In this patient, nintedanib was effective against RA-UIP. This is the first case in which nintedanib was shown to be effective for RA-UIP.
- Published
- 2019
- Full Text
- View/download PDF
13. Bronchial thermoplasty for severe uncontrolled asthma in Japan
- Author
-
Motoyasu Iikura, Masayuki Hojo, Naoko Nagano, Keita Sakamoto, Konomi Kobayashi, Shota Yamamoto, Masao Hashimoto, Satoru Ishii, Shinyu Izumi, and Haruhito Sugiyama
- Subjects
Immunologic diseases. Allergy ,RC581-607 - Published
- 2018
- Full Text
- View/download PDF
14. Clinical usefulness of end‐tidal CO 2 measured using a portable capnometer in patients with respiratory disease
- Author
-
Manabu Suzuki, Shota Fujimoto, Keita Sakamoto, Kentaro Tamura, Satoru Ishii, Motoyasu Iikura, Shinyu Izumi, Yuichiro Takeda, Masayuki Hojo, and Haruhito Sugiyama
- Subjects
Pulmonary and Respiratory Medicine ,Immunology and Allergy ,Genetics (clinical) - Published
- 2023
15. Digoxigenin‐labeled <scp>RNA</scp> probes for untranslated regions enable the isoform‐specific gene expression analysis of myosin heavy chains in whole‐mount in situ hybridization
- Author
-
Masafumi Tanji, Keitaro Wada, Keita Sakamoto, Yudai Ono, and Masafumi Inui
- Subjects
Cell Biology ,Developmental Biology - Abstract
Myosin heavy chains (MyHCs), which are encoded by myosin heavy chain (Myh) genes, are the most abundant proteins in myofiber. Among the 11 sarcomeric Myh isoform genes in the mammalian genome, 7 are mainly expressed in skeletal muscle. Myh genes/MyHC proteins share a common role as force producing units with highly conserved sequences, but have distinct spatio-temporal expression patterns. As such, the expression patterns of Myh genes/MyHC proteins are considered as molecular signatures of specific fiber types or the regenerative status of mammalian skeletal muscles. Immunohistochemistry is widely used for identifying MyHC expression patterns; however, this method is costly and is not ideal for whole-mount samples, such as embryos. In situ hybridization (ISH) is another versatile method for the analysis of gene expression, but is not commonly applied for Myh genes, partly because of the highly homologous sequences of Myh genes. Here we demonstrate that an ISH analysis with the untranslated region (UTR) sequence of Myh genes is cost-effective and specific method for analyzing the Myh gene expression in whole-mount samples. Digoxigenin (DIG)-labeled antisense probes for UTR sequences, but not for protein coding sequences, specifically detected the expression patterns of respective Myh isoform genes in both embryo and adult skeletal muscle tissues. UTR probes also revealed the isoform gene-specific polarized localization of Myh mRNAs in embryonic myofibers, which implied a novel mRNA distribution mechanism. Our data suggested that the DIG-labeled UTR probe is a cost-effective and versatile method to specifically detect skeletal muscle Myh genes in a whole-mount analysis.
- Published
- 2022
16. Characteristic Charge Collection Mechanism Observed in FinFET SRAM Cells
- Author
-
Kozo Takeuchi, Keita Sakamoto, Kazuki Yukumatsu, Kyota Watanabe, Yuta Tsuchiya, Takashi Kato, Hideya Matsuyama, Akinori Takeyama, Takeshi Ohshima, Satoshi Kuboyama, and Hiroyuki Shindo
- Subjects
Nuclear and High Energy Physics ,Nuclear Energy and Engineering ,Electrical and Electronic Engineering - Published
- 2022
17. Efficacy and safety of sotrovimab for vaccinated or unvaccinated patients with mild-to-moderate COVID-19 in the omicron era
- Author
-
Takehiro Izumo, Nobuyasu Awano, Naoyuki Kuse, Keita Sakamoto, Kohei Takada, Yutaka Muto, Kazushi Fujimoto, Ayae Saiki, Yu Ito, Hiroaki Ota, and Minoru Inomata
- Subjects
COVID-19 Vaccines ,SARS-CoV-2 ,COVID-19 ,Humans ,Viral Vaccines ,Pharmacology (medical) ,RNA, Messenger ,General Medicine ,General Pharmacology, Toxicology and Pharmaceutics ,Antibodies, Monoclonal, Humanized ,Antibodies, Viral ,Antibodies, Neutralizing ,COVID-19 Drug Treatment - Abstract
Although sotrovimab, one of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibodies has been shown to be effective in patients with mild-to-moderate coronavirus disease 2019 (COVID-19) with risk factors, their efficacy in mRNA COVID-19 vaccinated patients in omicron era is unknown. To evaluate the effectiveness of sotrovimab clinical data from both COVID-19 vaccinated and unvaccinated patients who were hospitalized and receiving sotrovimab at the Japanese Red Cross Medical Center were compared. The efficacy and adverse events were evaluated. Of the total 60 patients enrolled in this study, 45 had received the mRNA COVID-19 vaccine and 15 were unvaccinated. The clinical progression with low nasal cannula or face mask was not significantly different between groups (occurring in one patient in each group; p = 0.44), with no further progression in both groups. The duration of hospitalization was eight days for both groups (p = 0.90). Two patients in each group experienced adverse events (7%, p = 0.26). The results suggested that the efficacy and safety of sotrovimab against mild-to-moderate COVID-19 with risk factors in the omicron era might not be different regardless of the vaccination status. The results of the present study are encouraging; however, further randomized clinical studies are needed.
- Published
- 2022
18. Supplemental figure 3 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
- Author
-
Hideo Baba, Toru Beppu, Eiji Oki, Akira Chikamoto, Daisuke Hashimoto, Hidetoshi Nitta, Hideyuki Kuroki, Takatsugu Ishimoto, Yukiko Fukushima, Keita Sakamoto, Takayoshi Kaida, Naomi Yokoyama, Takaaki Higashi, and Hiromitsu Hayashi
- Abstract
Effects of YAP overexpression on phosphorylation of Erk1/2 in HuH1 cells.
- Published
- 2023
19. Supplemental methods from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
- Author
-
Hideo Baba, Toru Beppu, Eiji Oki, Akira Chikamoto, Daisuke Hashimoto, Hidetoshi Nitta, Hideyuki Kuroki, Takatsugu Ishimoto, Yukiko Fukushima, Keita Sakamoto, Takayoshi Kaida, Naomi Yokoyama, Takaaki Higashi, and Hiromitsu Hayashi
- Abstract
Supplemental methods
- Published
- 2023
20. Supplementary Figure Legends from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
- Author
-
Hideo Baba, Toru Beppu, Eiji Oki, Akira Chikamoto, Daisuke Hashimoto, Hidetoshi Nitta, Hideyuki Kuroki, Takatsugu Ishimoto, Yukiko Fukushima, Keita Sakamoto, Takayoshi Kaida, Naomi Yokoyama, Takaaki Higashi, and Hiromitsu Hayashi
- Abstract
Supplementary Figure Legends
- Published
- 2023
21. Supplemental figure 1 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
- Author
-
Hideo Baba, Toru Beppu, Eiji Oki, Akira Chikamoto, Daisuke Hashimoto, Hidetoshi Nitta, Hideyuki Kuroki, Takatsugu Ishimoto, Yukiko Fukushima, Keita Sakamoto, Takayoshi Kaida, Naomi Yokoyama, Takaaki Higashi, and Hiromitsu Hayashi
- Abstract
Knockdown of TAZ or YAP expression by siRNA duplex oligonucleotides.
- Published
- 2023
22. Data from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
- Author
-
Hideo Baba, Toru Beppu, Eiji Oki, Akira Chikamoto, Daisuke Hashimoto, Hidetoshi Nitta, Hideyuki Kuroki, Takatsugu Ishimoto, Yukiko Fukushima, Keita Sakamoto, Takayoshi Kaida, Naomi Yokoyama, Takaaki Higashi, and Hiromitsu Hayashi
- Abstract
Transcriptional coactivator with PDZ-binding motif (TAZ) and yes-associated protein (YAP) are equivalently placed downstream effectors of the Hippo pathway with oncogenic roles in human cancers. However, the expression profiles of TAZ/YAP differ depending on the cancer cell type, suggesting that these proteins have different roles during cancer progression, yet no studies have examined the biologic significance of the balance between TAZ and YAP expression levels. Here we examined the functional roles of TAZ/YAP in hepatocellular carcinoma progression. We found that TAZ, but not YAP, was predominantly expressed in HCC. TAZ knockdown under normal conditions attenuated cell growth in HCC cells; however, TAZ knockdown combined with 5-fluorouracil treatment significantly increased chemoresistance compared with control cells. Notably, TAZ knockdown induced compensatory YAP expression and was accompanied by upregulation of CD90, a HCC–specific cancer stem cell marker. Continuous treatment with 5-fluorouracil also induced YAP expression and promoted tumor formation in vivo. Conversely, double knockdown of TAZ/YAP reduced chemoresistance and tumorigenicity. Moreover, YAP knockdown aggravated HCC cell growth to a greater degree than TAZ knockdown, and YAP overexpression was strongly associated with poor prognoses in patients with HCC. Collectively, these studies demonstrate that TAZ and YAP exhibit different functional roles in cancer progression, and a shift to predominant YAP expression upon TAZ depletion conferred cancer stem cell–like properties including chemoresistance and tumorigenicity in HCC. Therefore, targeting of both TAZ/YAP will be required for a complete antitumor response in HCC. Cancer Res; 75(22); 4985–97. ©2015 AACR.
- Published
- 2023
23. Supplemental figure 2 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
- Author
-
Hideo Baba, Toru Beppu, Eiji Oki, Akira Chikamoto, Daisuke Hashimoto, Hidetoshi Nitta, Hideyuki Kuroki, Takatsugu Ishimoto, Yukiko Fukushima, Keita Sakamoto, Takayoshi Kaida, Naomi Yokoyama, Takaaki Higashi, and Hiromitsu Hayashi
- Abstract
Changes in cyclin D1 mRNA expression by TAZ knockdown in HCC cells
- Published
- 2023
24. Supplemental table 1 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
- Author
-
Hideo Baba, Toru Beppu, Eiji Oki, Akira Chikamoto, Daisuke Hashimoto, Hidetoshi Nitta, Hideyuki Kuroki, Takatsugu Ishimoto, Yukiko Fukushima, Keita Sakamoto, Takayoshi Kaida, Naomi Yokoyama, Takaaki Higashi, and Hiromitsu Hayashi
- Abstract
Characteristics of 110 patients with hepatocellular carcinoma
- Published
- 2023
25. Supplemental table 2 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
- Author
-
Hideo Baba, Toru Beppu, Eiji Oki, Akira Chikamoto, Daisuke Hashimoto, Hidetoshi Nitta, Hideyuki Kuroki, Takatsugu Ishimoto, Yukiko Fukushima, Keita Sakamoto, Takayoshi Kaida, Naomi Yokoyama, Takaaki Higashi, and Hiromitsu Hayashi
- Abstract
Association between TAZ or YAP mRNA expression and patient's characteristics in hepatocellular carcinoma
- Published
- 2023
26. Supplemental figure 4 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
- Author
-
Hideo Baba, Toru Beppu, Eiji Oki, Akira Chikamoto, Daisuke Hashimoto, Hidetoshi Nitta, Hideyuki Kuroki, Takatsugu Ishimoto, Yukiko Fukushima, Keita Sakamoto, Takayoshi Kaida, Naomi Yokoyama, Takaaki Higashi, and Hiromitsu Hayashi
- Abstract
YAP knockdown in other gastrointestinal cancer cells (SW620 and TE-1 cells) with high YAP expression.
- Published
- 2023
27. Supplemental figure 5 from An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell–like Behaviors Contributing to Disease Progression
- Author
-
Hideo Baba, Toru Beppu, Eiji Oki, Akira Chikamoto, Daisuke Hashimoto, Hidetoshi Nitta, Hideyuki Kuroki, Takatsugu Ishimoto, Yukiko Fukushima, Keita Sakamoto, Takayoshi Kaida, Naomi Yokoyama, Takaaki Higashi, and Hiromitsu Hayashi
- Abstract
qPCR analysis of EpCAM, CD133, and CD44 expressions in response to TAZ knockdown.
- Published
- 2023
28. Polarizing agents beyond pentacene for efficient triplet dynamic nuclear polarization in glass matrices
- Author
-
Keita Sakamoto, Tomoyuki Hamachi, Katsuki Miyokawa, Kenichiro Tateishi, Tomohiro Uesaka, Yuki Kurashige, and Nobuhiro Yanai
- Abstract
Triplet dynamic nuclear polarization (triplet-DNP) is a technique that can obtain high nuclear polarization under moderate conditions. However, in order to obtain practically useful polarization, large single crystals doped with a polarizing agent must be strictly oriented with respect to the magnetic field to sharpen the electron spin resonance (ESR) spectra, which is a fatal problem that prevents its application to truly useful biomolecular targets. Instead of this conventional physical approach of controlling crystal orientation, here, we propose a chemical approach, i.e., molecular design of polarizing agents; pentacene molecules, the most typical triplet-DNP polarizing agent, are modified so as to make the triplet electron distribution wider and more isotropic without loss of the triplet polarization. In fact, the modification of pentacene with thiophene moieties makes the ESR spectrum sharper and stronger than that of pentacene. To elucidate the effect of the substitutions on spin polarization and zero-field splitting parameters, which determine ESR spectrum, state-of-the-art quantum chemical calculations were performed and revealed that the direction of the spin polarization is altered by the modification with thiophene moieties and the size of D and E parameters are reduced from parent pentacene due to the partial delocalization of spin densities on the thiophene moieties. The triplet-DNP with the new polarizing agent successfully exceeds the previous highest 1H polarization of glassy materials by a factor of 5. This demonstrates the feasibility of a polarizing agent that can surpass pentacene, the best polarizing agent for more than 30 years since triplet-DNP was first reported, in the unoriented state. This work provides a pathway toward practically useful high nuclear polarization of various biomolecules by triplet-DNP.
- Published
- 2023
29. An SRAM SEU Cross Section Curve Physics Model
- Author
-
Daisuke, Kobayashi, Kazuyuki, Hirose, Keita, Sakamoto, Yuta, Tsuchiya, Shogo, Okamoto, Baba, Shunsuke, Hiroyuki, Shindou, Osamu, Kawasaki, Takahiro, Makino, and Takeshi, Ohshima
- Abstract
Static random access memories (SRAMs) are prone to a single-event upset (SEU), also known as soft errors, due to transient noise caused by a single strike of radiation. Beam testing has been extensively used to measure the SEU cross section of SRAMs as a function of the linear energy transfer (LET) of charged particle radiation. The evolution of the cross section as a function of LET is called the cross section curve, which plays a vital role in upset rate analysis for hardness assurance. Various analytical models have been developed to describe SRAM SEU cross section curves, and they have proven to be useful in reducing the cost of beam testing as well as revealing the physics behind test results. However, they involve arbitrary parameters, which make it challenging to predict cross section curves without any beam results. Moreover, the current method of analyzing cross section curves or the LET dependence of cross sections relies on a model different from that is used in the analysis of power-supply-voltage dependence, which is becoming increasingly important because of the demand for low-power operation. To overcome these problems, this article proposes a unified equation that describes both LET and the power-supply-voltage dependence of SRAM SEU cross sections. It comprises only parameters that are physically clear and familiar to SEU researchers. As well as giving possible constraints, comparisons with data from the literature suggest it can be applied to SRAMs fabricated in bulk and silicon-on-insulator (SOI) processes across generations from the early 1000-nm-scale to the current 10-nm-scale technology nodes.
- Published
- 2022
30. An SRAM SEU Cross Section Curve Physics Model
- Author
-
Shogo Okamoto, Keita Sakamoto, Takeshi Ohshima, Hiroyuki Shindou, Yuta Tsuchiya, Takahiro Makino, Daisuke Kobayashi, Kazuyuki Hirose, Osamu Kawasaki, and Shunsuke Baba
- Subjects
Physics ,Nuclear and High Energy Physics ,Cross section (physics) ,Transient noise ,Nuclear Energy and Engineering ,Electronic engineering ,Linear energy transfer ,Function (mathematics) ,Static random-access memory ,Electrical and Electronic Engineering ,Upset ,Beam (structure) ,Random access - Abstract
Static random access memories (SRAMs) are prone to a single-event upset (SEU), also known as soft errors, due to transient noise caused by a single strike of radiation. Beam testing has been extensively used to measure the SEU cross section of SRAMs as a function of the linear energy transfer (LET) of charged particle radiation. The evolution of the cross section as a function of LET is called the cross section curve, which plays a vital role in upset rate analysis for hardness assurance. Various analytical models have been developed to describe SRAM SEU cross-section curves, and they have proven to be useful in reducing the cost of beam testing as well as revealing the physics behind test results. However, they involve arbitrary parameters, which make it challenging to predict cross-section curves without any beam results. Moreover, the current method of analyzing cross-section curves or the LET dependence of cross sections relies on a model different from that is used in the analysis of power-supply-voltage dependence, which is becoming increasingly important because of the demand for low-power operation. To overcome these problems, this paper proposes a unified equation that describes both LET and the power-supply-voltage dependence of SRAM SEU cross sections. It comprises only parameters that are physically clear and familiar to SEU researchers. As well as giving possible constraints, comparisons with data from the literature suggest it can be applied to SRAMs fabricated in bulk and silicon-on-insulator (SOI) processes across generations from the early 1000-nm-scale to the current 10-nm-scale technology nodes.
- Published
- 2022
31. High-flow nasal cannula for severe COVID-19 patients in a Japanese single-center, retrospective, observational study: 1 year of clinical experience
- Author
-
Takashi Katsuno, Manabu Suzuki, Momoko Morishita, Kazuki Kawajiri, Susumu Saito, Yuriko Horikawa, Yuriko Ueki, Yoh Yamaguchi, Hiroshi Takumida, Hiromu Watanabe, Chie Morita, Akinari Tsukada, Yusaku Kusaba, Yoshie Tsujimoto, Akane Ishida, Keita Sakamoto, Masao Hashimoto, Junko Terada, Jin Takasaki, Shinyu Izumi, Masayuki Hojo, and Haruhito Sugiyama
- Subjects
Original Article ,General Medicine - Abstract
High-flow nasal cannula (HFNC) can be effective in treating type 1 respiratory failure by reducing the severity of coronavirus disease 2019 (COVID-19). The purpose of this study was to assess the reduction of disease severity and safety of HFNC treatment in patients with severe COVID-19. We retrospectively observed 513 consecutive patients with COVID-19 admitted to our hospital from January 2020 to January 2021. We included patients with severe COVID-19 who received HFNC for their deteriorating respiratory status. HFNC success was defined as improvement in respiratory status after HFNC and transfer to conventional oxygen therapy, while HFNC failure was defined as transfer to non‐invasive positive pressure ventilation or ventilator, or death after HFNC. Predictive factors associated with failure to prevent severe disease were identified. Thirty-eight patients received HFNC. Twenty-five (65.8%) patients were classified in the HFNC success group. In the univariate analysis, age, history of chronic kidney disease (CKD), non-respiratory sequential organ failure assessment (SOFA) ≥ 1, oxygen saturation to fraction of inspired oxygen ratio (SpO(2)/FiO(2)) before HFNC ≤ 169.2, were significant predictors of HFNC failure. Multivariate analysis revealed that SpO(2)/FiO(2) value before HFNC ≤ 169.2 was an independent predictor of HFNC failure. No apparent nosocomial infection occurred during the study period. Appropriate use of HFNC for acute respiratory failure caused by COVID-19 can reduce the severity of severe disease without causing nosocomial infection. Age, history of CKD, non-respiratory SOFA before HFNC ≤ 1, and SpO(2)/FiO(2) before HFNC ≤ 169.2 were associated with HFNC failure.
- Published
- 2023
32. Triplet Dynamic Nuclear Polarization of Pyruvate via Supramolecular Chemistry
- Author
-
Tomoyuki Hamachi, Koki Nishimura, Keita Sakamoto, Yusuke Kawashima, Hironori Kouno, Shunsuke Sato, Go Watanabe, Kenichiro Tateishi, Tomohiro Uesaka, and Nobuhiro Yanai
- Abstract
Dynamic nuclear polarization (DNP) significantly improves the sensitivity of magnetic resonance imaging, and its most important medical application is cancer diagnosis via hyperpolarized 13C-labeled pyruvate. Unlike cryogenic DNP, triplet-DNP uses photoexcited triplet electrons under mild conditions. However, triplet-DNP of pyruvate has not been observed because of incompatibility of the hydrophobic polarizing agent with hydrophilic pyruvate. This work demonstrates that supramolecular complexation with β-cyclodextrin can disperse 4,4′-(pentacene-6,13-diyl)dibenzoate (NaPDBA), a pentacene derivative with hydrophilic substituents, even in the presence of high sodium pyruvate concentrations. The polarization of photoexcited triplet electron spins in NaPDBA was transferred to the 13C spins of sodium pyruvate via triplet-DNP of 1H spins in water and 1H-to-13C cross-polarization. This provides an important step toward the widespread use of ultra-sensitive MRI for cancer diagnosis.
- Published
- 2023
33. Diagnostic Accuracy of Direct Reverse Transcription-Polymerase Chain Reactionusing Guanidine-Based and Guanidine-Free Inactivators for SARS-CoV-2 Detection in Saliva Samples
- Author
-
Takashi Katsuno, Moto Kimura, Junko Terada-Hirashima, Yukumasa Kazuyama, Masato Ikeda, Ataru Moriya, Masami Kurokawa, Ayano Motohashi, Erina Isaka, Momoko Morishita, Kazuki Kawajiri, Kazuo Hakkaku, Susumu Saito, Yuriko Terayama, Yuriko Sugiura, Yoh Yamaguchi, Hiroshi Takumida, Hiromu Watanabe, Chie Morita, Akinari Tsukada, Yusaku Kusaba, Yoshie Tsujimoto, Akane Ishida, Keita Sakamoto, Masao Hashimoto, Manabu Suzuki, Jin Takasaki, Shinyu Izumi, Masayuki Hojo, Haruhito Sugiyama, and Wataru Sugiura
- Published
- 2023
34. Atelocollagen-associated autologous chondrocyte implantation for the repair of large cartilage defects of the knee: Results at three to seven years
- Author
-
Takuma Kaibara, Eiji Kondo, Masatake Matsuoka, Koji Iwasaki, Tomohiro Onodera, Keita Sakamoto, Yoshitaka Oda, Zen-ichi Tanei, Daisuke Momma, Shinya Tanaka, and Norimasa Iwasaki
- Subjects
Orthopedics and Sports Medicine ,Surgery - Published
- 2023
35. Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19
- Author
-
Nobuyasu Awano, Kazushi Fujimoto, Takehiro Izumo, Mari Tone, Yutaka Muto, Yu Ito, Ayae Saiki, Naoyuki Kuse, Haruko Matsumoto, Keita Sakamoto, Kohei Takada, and Minoru Inomata
- Subjects
Male ,medicine.medical_treatment ,efficacy ,adverse event ,Dexamethasone ,law.invention ,PCR, polymerase chain reaction ,law ,COVID-19, coronavirus disease 2019 ,Janus kinase inhibitor ,Sulfonamides ,Alanine ,Mortality rate ,eGFR, estimated glomerular filtration rate ,ACTT-2, Adaptive COVID-19 Treatment Trial 2 ,Middle Aged ,Intensive care unit ,BRD, baricitinib: remdesivir: and dexamethasone ,Treatment Outcome ,Original Article ,Drug Therapy, Combination ,Female ,severe acute respiratory syndrome coronavirus 2 ,medicine.drug ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Combination therapy ,SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 ,coronavirus disease 2019 ,Internal medicine ,medicine ,Humans ,Adverse effect ,IQR, interquartile range ,Aged ,Mechanical ventilation ,SARS-CoV-2 ,business.industry ,COVID-19 ,acute respiratory distress syndrome ,medicine.disease ,Respiration, Artificial ,Adenosine Monophosphate ,COVID-19 Drug Treatment ,Pneumonia ,SpO2, blood oxygen saturation ,Purines ,CTCAE, Common Terminology Criteria for Adverse Events ,Azetidines ,Pyrazoles ,business - Abstract
Background Coronavirus disease 2019 (COVID-19) has spread worldwide and is also an important disease in Japan. Thus, the optimal treatment strategy for severe COVID-19 should be established urgently. The effects of combination treatment with baricitinib—a Janus kinase inhibitor, remdesivir, and dexamethasone (BRD) are unknown. Methods Patients who received combination therapy with BRD at the Japanese Red Cross Medical Center were enrolled in the study. All patients received baricitinib (≤14 d), remdesivir (≤10 d), and dexamethasone (≤10 d). The efficacy and adverse events were evaluated. Results In total, 44 patients with severe COVID-19 were enrolled in this study. The 28-d mortality rate was low at 2.3% (1/44 patients). The need for invasive mechanical ventilation was avoided in most patients (90%, 17/19 patients). Patients who received BRD therapy had a median hospitalization duration of 11 d, time to recovery of 9 d, duration of intensive care unit stay of 6 d, duration of invasive mechanical ventilation of 5 d, and duration of supplemental oxygen therapy of 5 d. Adverse events occurred in 15 patients (34%). Liver dysfunction, thrombosis, iliopsoas hematoma, renal dysfunction, ventilator-associated pneumonia, infective endocarditis, and herpes zoster occurred in 11%, 11%, 2%, 2%, 2%, 2%, and 2% of patients, respectively. Conclusions Combination therapy with BRD was effective in treating severe COVID-19, and the incidence rate of adverse events was low. The results of the present study are encouraging; however, further randomized clinical studies are needed.
- Published
- 2021
36. A Kidney Transplant Patient Who Died of COVID-19-associated Severe Acute Respiratory Distress Syndrome
- Author
-
Yuya Kishino, Toru Igari, Masayuki Hojo, Junko Terada, Yusaku Kusaba, Yoshie Tsujimoto, Keita Sakamoto, Jin Takasaki, Takashi Katsuno, Shinyu Izumi, Masao Hashimoto, Manabu Suzuki, Tadaki Suzuki, Yuko Sato, Noriko Nakajima, Haruhito Sugiyama, Akinari Tsukada, and Kento Misumi
- Subjects
Male ,kidney transplant ,medicine.medical_specialty ,medicine.medical_treatment ,Case Report ,Autopsy ,Azithromycin ,Gastroenterology ,Virus ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Lung ,Kidney transplantation ,Aged ,immunosuppressed ,Mechanical ventilation ,Respiratory Distress Syndrome ,Coronavirus disease 2019 ,SARS-CoV-2 ,business.industry ,COVID-19 ,Hydroxychloroquine ,General Medicine ,respiratory system ,medicine.disease ,Kidney Transplantation ,medicine.anatomical_structure ,Respiratory failure ,business ,medicine.drug - Abstract
We herein report a 67-year-old kidney transplant patient who died of COVID-19. He was treated with hydroxychloroquine and azithromycin and received mechanical ventilation that temporarily improved his respiratory status. Despite our efforts, however, he later developed respiratory failure and died 43 days after the disease onset. The autopsy revealed prominent organization of alveoli and alveolar ducts, with a massive accumulation of macrophages in the lungs. A few severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antigen-positive cells were detected in the lung, suggesting delayed virus clearance owing to his long-term immunosuppressed state, leading to constant lung damage and ultimately respiratory failure.
- Published
- 2021
37. Investigation of Buried-Well Potential Perturbation Effects on SEU in SOI DICE-Based Flip-Flop Under Proton Irradiation
- Author
-
Keita, Sakamoto, Baba, Shunsuke, Daisuke, Kobayashi, Shogo, Okamoto, Shindou, Hiroyuki, Osamu, Kawasaki, Takahiro, Makino, Mori, Yoshiharu, Matuura, Daisuke, Kusano, Masaki, Takanori, Narita, Shigeru, Ishii, Kazuyuki, Hirose, and Masaki, Kusano
- Abstract
The effects of buried-well potential perturbation under the buried-oxide (BOX) layer are studied in both a heavy-ion single event upset (SEU) test and a high-energy proton-SEU test of a silicon-on-insulator (SOI) dual interlocked storage cell (DICE)-based flip-flop. Their dependence on incident angle and back bias is discussed. We fabricated both DICE-based flip-flop and conventional flip-flop, which are designed as 80 000-stage shift-register chains. In a heavy-ion test, a considerable number of SEUs were observed at back bias exceeding 2.4 V, and a ten-times larger SEU-cross section was finally recorded at back bias of 3.0 V compared with the total active area of a DICE-based flip-flop cell. This marks the first case where DICE topology was found to be broken by buried-well potential perturbation on an SOI DICE-based flip-flop. In a proton test, one error was observed at back bias of 2.0 V. The SEU rate in the Van Allen belt at an altitude of 2300 km and an inclination of 90° was estimated as being once every 5 years.
- Published
- 2021
38. Investigation of Buried-Well Potential Perturbation Effects on SEU in SOI DICE-Based Flip-Flop Under Proton Irradiation
- Author
-
Masaki Kusano, Takanori Narita, Shogo Okamoto, Yoshiharu Mori, Kazuyuki Hirose, Osamu Kawasaki, Shigeru Ishii, Takahiro Makino, Hiroyuki Shindou, Keita Sakamoto, Shunsuke Baba, Daisuke Matuura, and Daisuke Kobayashi
- Subjects
Physics ,Nuclear and High Energy Physics ,Proton ,Transistor ,Silicon on insulator ,Dice ,Topology (electrical circuits) ,Computational physics ,law.invention ,symbols.namesake ,Nuclear Energy and Engineering ,Single event upset ,law ,Van Allen radiation belt ,symbols ,Electrical and Electronic Engineering ,Flip-flop - Abstract
The effects of buried-well potential perturbation under the buried-oxide (BOX) layer are studied in both a heavy-ion single event upset (SEU) test and a high-energy proton-SEU test of a silicon-on-insulator (SOI) dual interlocked storage cell (DICE)-based flip-flop. Their dependence on incident angle and back bias is discussed. We fabricated both DICE-based flip-flop and conventional flip-flop, which are designed as 80 000-stage shift-register chains. In a heavy-ion test, a considerable number of SEUs were observed at back bias exceeding 2.4 V, and a ten-times larger SEU-cross section was finally recorded at back bias of 3.0 V compared with the total active area of a DICE-based flip-flop cell. This marks the first case where DICE topology was found to be broken by buried-well potential perturbation on an SOI DICE-based flip-flop. In a proton test, one error was observed at back bias of 2.0 V. The SEU rate in the Van Allen belt at an altitude of 2300 km and an inclination of 90° was estimated as being once every 5 years.
- Published
- 2021
39. Clinical usefulness of end-tidal CO
- Author
-
Manabu, Suzuki, Shota, Fujimoto, Keita, Sakamoto, Kentaro, Tamura, Satoru, Ishii, Motoyasu, Iikura, Shinyu, Izumi, Yuichiro, Takeda, Masayuki, Hojo, and Haruhito, Sugiyama
- Abstract
This study aimed to evaluate the correlation and agreement between end-tidal COWe analyzed the correlation and the agreement between EtCOA total of 100 samples were included that comprised 67 men (67%). The mean age of the subjects was 77 ± 13 years. Chronic obstructive pulmonary disease (COPD) (43%) was the most common disease. There was a high correlation between EtCOEtCO
- Published
- 2022
40. Rheumatologic manifestations with elevated levels of IL-6, IL-17A, and IL-23 in a patient with scurvy
- Author
-
Masahiro Ueki, Keita Sakamoto, Noriko Nishioka, Hiroki Ohata, Takiko Nobuta, Shunichiro Takezaki, Atsushi Manabe, and Masafumi Yamada
- Subjects
Rheumatology - Abstract
Symptomatic vitamin C deficiency, scurvy, is a relatively rare disease in developed countries, but it has been reported in patients with autism spectrum disorder or developmental delay who tend to have selective diets. Patients with scurvy often demonstrate musculoskeletal manifestations with unknown pathophysiology. Herein, we report a case of scurvy in an 11-year-old boy who presented with iron-deficiency anaemia, systemic osteomyelitis, myositis predominantly in the lower extremities, and right ventricular volume overload with mild pulmonary hypertension and was diagnosed with scurvy. He had a mild developmental disorder and a selective diet, which resulted in severe vitamin C deficiency. He received intravenous and oral vitamin C supplementation, which relieved his arthralgia and muscle pain in a week. Following 4 months of vitamin C supplementation, he demonstrated no abnormal manifestations on laboratory or imaging examination and recovered without sequelae. Inflammatory cytokine and chemokine evaluations demonstrated elevated levels of interleukin (IL)-6, IL-17A, and IL-23, which are associated with T-helper (Th) 17 cell activation. This study is the first to suggest the association between the inflammation seen in scurvy, rheumatic manifestations in the patient, and Th17 cell activation. Further analysis of the association between the inflammation and vitamin C supplementation may contribute to new insights for the comprehension and treatment of other inflammatory diseases, such as rheumatic diseases.
- Published
- 2022
41. Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid
- Author
-
Masayuki Hojo, Keita Sakamoto, Satoru Ishii, Masao Hashimoto, Shinyu Izumi, Jin Takasaki, Toru Igari, Manabu Suzuki, Mariko Tanaka, and Hiroshi Takumida
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,medicine.drug_class ,Case Report ,RT-PCR, real-time polymerase chain reaction ,SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,COVID-19, novel coronavirus disease 2019 ,Respiratory function ,Cryobiopsy ,030212 general & internal medicine ,Respiratory system ,Steroid ,Organizing pneumonia ,Oxygen saturation (medicine) ,Lung ,business.industry ,COVID-19 ,medicine.disease ,OP, organizing pneumonia ,CT, computed tomography ,Pneumonia ,medicine.anatomical_structure ,030228 respiratory system ,Respiratory failure ,CRP, C-reactive protein ,Prednisolone ,SP-D, surfactant protein D ,DAD, diffuse alveolar damage ,Corticosteroid ,BAL, bronchoalveolar lavage ,PaO2, partial pressure of arterial oxygen ,business ,medicine.drug - Abstract
A 70-year-old Japanese man contracted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and required oxygen to maintain oxygen saturation (>90%), 5 weeks after onset of coronavirus disease 2019 (COVID-19) symptoms. Transbronchial lung cryobiopsy revealed pathological features of organizing pneumonia with alveolar epithelial injury, and prednisolone administration led to alleviation of respiratory symptoms and recovery of respiratory function. This case report is the first to demonstrate the use of corticosteroids to successfully treat post-COVID-19 respiratory failure in a patient with biopsy-proven organizing pneumonia. We propose that steroid treatment be considered for patients with persistent respiratory dysfunction as COVID-19 pneumonia sequelae.
- Published
- 2021
42. Evaluation of whole-body modalities for diagnosis of multifocal osteonecrosis—a pilot study
- Author
-
Daisuke Takahashi, Norimasa Iwasaki, Tsuyoshi Asano, Keita Sakamoto, Shunichi Yokota, Tomohiro Shimizu, Kohsuke Kudo, and Yukie Shimizu
- Subjects
medicine.medical_specialty ,Letter ,lcsh:Diseases of the musculoskeletal system ,Whole-body bone scintigraphy ,Pilot Projects ,Asymptomatic ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Femoral head ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,Whole Body Imaging ,Radionuclide Imaging ,Steroid ,030203 arthritis & rheumatology ,medicine.diagnostic_test ,business.industry ,Osteonecrosis ,Magnetic resonance imaging ,medicine.disease ,Magnetic Resonance Imaging ,Rheumatology ,medicine.anatomical_structure ,Hematologic disease ,Bone scintigraphy ,Orthopedic surgery ,Radiology ,Whole-body magnetic resonance imaging ,medicine.symptom ,lcsh:RC925-935 ,business ,Body mass index - Abstract
BackgroundThis study aimed to investigate the ability of whole-body bone scintigraphy (WB-BS) in the detection of multifocal osteonecrosis (ON) compared to whole-body magnetic resonance imaging (WB-MRI) and to clarify the characteristics of patients with multifocal ON among those with ON of the femoral head (ONFH) using WB-MRI.MethodsForty-six patients who had symptomatic ONFH and underwent surgery in our hospital from April 2019 to October 2020 were included in the study. Data on patient demographics, including age, sex, body mass index (BMI), history of corticosteroid intake, alcohol abuse, smoking, and symptomatic joints, were collected from their medical records. All patients underwent WB-MRI and WB-BS before surgery.ResultsThe agreement in the detection of ON by WB-MRI vs the uptake lesions by WB-BS in the hip joints was moderate (κ = 0.584), while that in other joints was low (κ P = 0.035). The patients with a hematologic disease had multifocal ON at a higher rate (P = 0.015).ConclusionsIt might be difficult for WB-BS to detect the asymptomatic ON detected by WB-MRI compared to symptomatic ON. Considering the cost, examination time, and radiation exposure, WB-MRI might be useful for evaluating multifocal ON. Larger longitudinal studies evaluating the benefits of WB-MRI for detecting the risk factors for multifocal ON are required.
- Published
- 2021
43. Clinical utility of single-shot echo-planar diffusion-weighted imaging using L1-regularized iterative sensitivity encoding in prostate MRI
- Author
-
Noriko Nishioka, Noriyuki Fujima, Satonori Tsuneta, Masami Yoneyama, Ryuji Matsumoto, Takashige Abe, Rina Kimura, Keita Sakamoto, Fumi Kato, and Kohsuke Kudo
- Subjects
General Medicine - Published
- 2023
44. Direct hemoperfusion using a polymyxin B‐immobilized polystyrene column for <scp>COVID</scp> ‐19
- Author
-
Masaya Sugiyama, Fumihiko Hinoshita, Tetsuya Suzuki, Masayuki Hojo, Yusuke Miyazato, Yusaku Kusaba, Tomiteru Togano, Masao Hashimoto, Tatsunori Ogawa, Isao Kondo, Manabu Suzuki, Keita Sakamoto, Takato Nakamoto, Satoshi Ide, Takashi Katsuno, Yutaro Akiyama, Jin Takasaki, Tatsuya Okamoto, Norio Ohmagari, Shinyu Izumi, Daisuke Katagiri, Masahiro Ishikane, Hidetoshi Nomoto, Noriko Kinoshita, Akio Kimura, Masashi Mizokami, Eisei Noiri, Yusuke Asai, Haruhito Sugiyama, Hiyori Katsuoka, Takashi Fukaya, and Keiji Nakamura
- Subjects
Male ,medicine.medical_treatment ,Polymyxin ,Urine ,030204 cardiovascular system & hematology ,Gastroenterology ,chemistry.chemical_compound ,0302 clinical medicine ,cytokine ,Research Articles ,Polymyxin B ,Aged, 80 and over ,Arteries ,Hematology ,General Medicine ,Middle Aged ,Hemoperfusion ,Hospitalization ,Vascular endothelial growth factor ,Cytokines ,Female ,Research Article ,steroids ,medicine.drug ,Adult ,Risk ,medicine.medical_specialty ,medicine.drug_class ,03 medical and health sciences ,Internal medicine ,medicine ,Extracorporeal membrane oxygenation ,Humans ,pneumonia ,Aged ,Retrospective Studies ,Fibrin degradation product ,business.industry ,Therapeutic effect ,COVID-19 ,Respiration, Artificial ,Oxygen ,chemistry ,Polystyrenes ,Endothelium, Vascular ,Blood Gas Analysis ,beta 2-Microglobulin ,business ,Biomarkers ,030215 immunology - Abstract
Objective To evaluate the efficacy and safety of direct hemoperfusion using a polymyxin B‐immobilized polystyrene column (PMX‐DHP) in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐positive pneumonia patients. Methods This study was a case series conducted at a designated infectious diseases hospital. Twelve SARS‐CoV‐2‐positive patients with partial pressure of arterial oxygen/percentage of inspired oxygen (P/F) ratio
- Published
- 2020
45. Unified Total Synthesis of (−)‐Enigmazole A and (−)‐15‐ O ‐Methylenigmazole A
- Author
-
Keisuke Sakurai, Makoto Sasaki, Keita Sakamoto, and Haruhiko Fuwa
- Subjects
Olefin fiber ,Addition reaction ,010405 organic chemistry ,Chemistry ,Stereochemistry ,Organic Chemistry ,Total synthesis ,General Chemistry ,Tetrahydropyran ,010402 general chemistry ,Ring (chemistry) ,Metathesis ,01 natural sciences ,Biochemistry ,0104 chemical sciences ,chemistry.chemical_compound ,Cascade reaction ,Intramolecular force - Abstract
The total synthesis of cytotoxic marine phosphomacrolides, (-)-enigmazole A and (-)-15-O-methylenigmazole A, is described in detail. The 2,6-cis-substituted tetrahydropyran ring was efficiently elaborated by using a tandem olefin cross-metathesis/intramolecular oxa-Michael addition reaction. The 18-membered macrolactone skeleton was forged via a Au-catalyzed propargylic benzoate rearrangement/macrocyclic ring-closing metathesis sequence. Late-stage diversification of a common intermediate enabled unified total synthesis of (-)-enigmazole A and (-)-15-O-methylenigmazole A.
- Published
- 2020
46. Changes in paddy soil fertility in Thailand due to the Green Revolution during the last 50 years
- Author
-
Porntiva Kanyawongha, Mina Hirose, Shin Abe, Keita Sakamoto, Anongnat Sriprachote, Sota Tanaka, Ketsuda Dejbhimon, Junta Yanai, Atsushi Nakao, and Thanakorn Lattirasuvan
- Subjects
0106 biological sciences ,Agroforestry ,business.industry ,Soil Science ,04 agricultural and veterinary sciences ,Plant Science ,Carbon sequestration ,01 natural sciences ,Soil resources ,Geography ,Plant science ,Sustainable management ,Agriculture ,040103 agronomy & agriculture ,0401 agriculture, forestry, and fisheries ,Soil fertility ,business ,Green Revolution ,Tropical Asia ,010606 plant biology & botany - Abstract
Understanding of the long-term soil fertility trends is the basis for rational and sustainable management of the soil resources in agricultural fields. In tropical Asia, the Green Revolution initia...
- Published
- 2020
47. Pembrolizumab‐induced pancytopenia in a patient with squamous cell lung cancer
- Author
-
Satoru Ishii, Junko Terada, Masayuki Hojo, Keita Sakamoto, Takashi Katsuno, Shinyu Izumi, Yuichiro Takeda, Yoh Yamaguchi, Yoshie Tsujimoto, Motoyasu Iikura, Haruhito Sugiyama, Yusaku Kusaba, Hiromu Watanabe, Masao Hashimoto, Jin Takasaki, Chie Morita, Yuriko Ueki, Yuriko Horikawa, Akinari Tsukada, Go Naka, Hiroshi Takumida, and Manabu Suzuki
- Subjects
0301 basic medicine ,Pulmonary and Respiratory Medicine ,Oncology ,medicine.medical_specialty ,Lung Neoplasms ,Immune checkpoint inhibitors ,Case Report ,Case Reports ,Pembrolizumab ,Immune checkpoint inhibitor ,immune‐related adverse event (irAE) ,Antibodies, Monoclonal, Humanized ,Squamous cell lung cancer ,lcsh:RC254-282 ,pancytopenia ,03 medical and health sciences ,Antineoplastic Agents, Immunological ,0302 clinical medicine ,squamous cell lung cancer ,Internal medicine ,PD-L1 ,medicine ,Humans ,Neoplasm ,Adverse effect ,Aged, 80 and over ,biology ,business.industry ,Incidence (epidemiology) ,General Medicine ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Pancytopenia ,030104 developmental biology ,PD‐L1 ,030220 oncology & carcinogenesis ,Carcinoma, Squamous Cell ,biology.protein ,Female ,business - Abstract
Immune checkpoint inhibitors (ICIs) are reportedly effective against many kinds of neoplasm, but may be responsible for several kinds of immune‐related adverse events (irAEs). Among these irAEs, the incidence of myelosuppression due to ICIs is relatively low. Corticosteroids are needed to control most cases of myelosuppression. Here, we report an 88‐year‐old woman with squamous cell lung cancer who was administered pembrolizumab. After five cycles of pembrolizumab, she developed severe pancytopenia. The pancytopenia improved under observation without steroid administration after cessation of pembrolizumab. During recovery from this irAE, the patient also maintained long‐term antitumor efficacy. Key points Significant findings of the study There are several kinds of immune‐related adverse events. We encountered a case of pembrolizumab‐induced pancytopenia with squamous cell lung cancer. What this study adds Corticosteroids are needed to control most cases of myelosuppression induced by ICIs, but pancytopenia induced by pembrolizumab in our case improved without steroids., An 88‐year‐old woman with squamous cell lung cancer was administered pembrolizumab. After 5 cycles of pembrolizumab, she developed severe pancytopenia. Pancytopenia improved under observation without steroid administration after cessation of pembrolizumab. During recovery from this irAE, the patient also maintained long‐term anti‐tumor efficacy.
- Published
- 2020
48. PROPOSAL OF MECHANICAL MODEL CONSIDERING STRESS FIELD OF JOINT SURFACE IN THE CASE OF COMBINED USE OF POST-INSTALLED ANCHOR AND CYLINDRICAL SHEAR-KEY
- Author
-
Takahide Abe, Yuya Takase, Keita Sakamoto, Keiichi Katori, and Takeshi Hiwatashi
- Subjects
Stress field ,Shear (geology) ,business.industry ,Architecture ,Combined use ,Joint surface ,Building and Construction ,Structural engineering ,business ,Geology - Published
- 2020
49. Nuclear protein of the testis midline carcinoma of the thorax
- Author
-
Ayae Saiki, Keita Sakamoto, Yuan Bee, and Takehiro Izumo
- Subjects
Male ,Cancer Research ,Oncogene Proteins, Fusion ,Carcinoma ,Nuclear Proteins ,General Medicine ,Chemoradiotherapy ,Thorax ,Young Adult ,Oncology ,Testicular Neoplasms ,Humans ,Radiology, Nuclear Medicine and imaging ,Child - Abstract
Nuclear protein of the testis (NUT) midline carcinoma (NMC) is a rare tumor that typically presents in the head, neck, and chest region. NMC is characterized by rearrangement of the NUTM1 gene. It mainly affects children and young adults and is rapidly progressive and lethal. Reportedly, the prognoses of NMCs of the head and neck improve following aggressive initial surgical resection +/− postoperative chemoradiotherapy (CRT) or radiotherapy (RT). However, as NMC of the thorax was identified later, treatments to improve its prognosis are yet to be identified. Our review reveals that NMC is an extremely rare cancer, and most patients remain undiagnosed. Furthermore, this review outlines the clinical characteristics of NMC of the thorax and the prospects for its treatment.
- Published
- 2022
50. Long‐term changes in paddy soil fertility in tropical Asia after 50 years of the Green Revolution
- Author
-
Haruyoshi Saito, Khairul Hafiz Mohd Yusoff, Kazutake Kyuma, Junta Yanai, Mina Hirose, Atsushi Nakao, Nicola Timbas, Toshiyuki Wakatsuki, Sota Tanaka, Susumu S. Abe, Nao Kajiwara, Simplicio Medina, Ketsuda Dejbhimon, Fukiko Masai, Anongnat Sriprachote, Thanakorn Lattirasuvan, Porntiva Kanyawongha, Keita Sakamoto, and Tan Ngai Paing
- Subjects
chemistry.chemical_classification ,Geography ,chemistry ,Agroforestry ,Phosphorus ,Soil Science ,chemistry.chemical_element ,Organic matter ,Soil fertility ,Green Revolution ,Tropical Asia ,Term (time) - Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.